Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder

Author： Lopez-Ibor J.J. Saiz J. Cottraux J. Note I. Vinas R. Bourgeois M. Hernandez M. Gomez-Perez J.C.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.6, Iss.2, 1996-05, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

By Sasson Y. Iancu I. Fux M. Taub M. Dannon P.N. Zohar J.

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 191-196

Elsevier

Access to resources Recommend Favorite

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

By Dannon P.N. Sasson Y. Hirschmann S. Iancu I. Grunhaus L.J. Zohar J.

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 165-169

Elsevier

Access to resources Recommend Favorite

Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder

By Koran L.M. Pallanti S. Paiva R.S. Quercioli L.

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 121-126

Elsevier

Access to resources Recommend Favorite

A Placebo controlled double blind study in obsessive compulsive disorder with fluvoxamine

By Kudo Y.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 371-372

Elsevier

Access to resources Recommend Favorite

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

By Askari Neda

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite